News | RIVM

Mpox vaccinations in 2022

More than 18 thousand people in the Netherlands have received one or more mpox vaccinations. The vaccination campaign was launched late last July, shortly after the outbreak began, and ended last month.

Science Photo Library / ANP

Vaccination campaign to end as number of monkeypox infections consistently low

The current monkeypox outbreak is virtually over, and therefore the vaccination campaign to stop the spread of monkeypox, or ‘apenpokken’ in Dutch, will soon be coming to an end.

One-third of target group now vaccinated against monkeypox

10,440 monkeypox vaccinations have already been administered in the Netherlands in the last few weeks. That represents about one-third of the target group currently eligible to get the vaccine against monkeypox.

Science Photo Library / ANP

Number of monkeypox infections continues to rise

More than 16,000 cases of monkeypox have now been confirmed worldwide, spread across 75 countries. Both the number of confirmed cases and the number of countries where the disease is present are continuing to rise

Monkeypox continues spreading

Over the past few weeks, 288 people in the Netherlands have tested positive for monkeypox. The number of new daily infections seems to be slowly increasing.

Science Photo Library / ANP

6 people in the Netherlands with monkeypox

There are now 6 cases of monkeypox in humans in the Netherlands.

Science Photo Library / ANP

First patient with monkeypox in the Netherlands

This afternoon, a patient with monkeypox was confirmed in the Netherlands for the first time. RIVM researchers confirmed that the person has monkeypox with a PCR test.

Science Photo Library / ANP

Start cervical cancer screening on Saba

February 7th 2022, a pilot for population screening for cervical cancer will start on Saba. All women between 30 and 60 years, will be invited to participate in the coming three years.

Breast cancer screening resumes on Bonaire after COVID-19 hiatus

Women aged 50 to 75 years on Bonaire can participate in the breast cancer screening programme again as of Wednesday, May 26, 2021. This was temporarily halted in 2020 due to the COVID-19 pandemic.

EFSA agrees with RIVM that potential effect of BPA on the immune system requires further attention

RIVM expressed concerns on the effects of bisphenol a (BPA) on the immune system in a report issued in March 2016.